TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development September 13, 1974
TCL Archive In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President October 16, 1981
TCL Archive Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership September 20, 2013
